What's in Kexing Biopharm Co., Ltd.'s pipeline?

Kexing Biopharm Co., Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Kexing Biopharm Co., Ltd.'s portfolio?

Top competitors by shared drug class: ANRS, Emerging Infectious Diseases, Ain Shams University, Beijing 302 Hospital, Dr. Conrado Fernandez, Foundation for Liver Research.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kexing-biopharm-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Kexing Biopharm Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kexing Biopharm Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Human interferon α1b Inhalation Solution	Human interferon α1b Inhalation Solution	phase 3	Interferon alpha	Interferon-alpha receptor (IFNAR)	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ANRS, Emerging Infectious Diseases · 1 shared drug class
Ain Shams University · 1 shared drug class
Beijing 302 Hospital · 1 shared drug class
Dr. Conrado Fernandez · 1 shared drug class
Foundation for Liver Research · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Merck & Co. · 1 shared drug class
Vertex Pharmaceuticals Incorporated · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kexing Biopharm Co., Ltd.:

Cite this brief

Drug Landscape (2026). Kexing Biopharm Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kexing-biopharm-co-ltd. Accessed 2026-05-16.